Effects of single intravitreal rhEPO injection on light-induced retinal injury in rats

Current Eye Research

Volumn 36, Issue 8, 2011, Pages 739-746

  Gong, Yuanyuan ^a   Qiu, Yating ^a   Song, Zhengyu ^a   Gu, Qin ^a   Wu, Xingwei ^a   Sun, Xiaodong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Apoptosis; Electroretinogram; Intravitreal injection; Light injury; Retina; RhEPO; Time dose effects

Indexed keywords

CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BCL XL; PROTEIN KINASE B; RECOMBINANT ERYTHROPOIETIN; STAT5 PROTEIN;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOWN REGULATION; DRUG EFFECT; LIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA INJURY; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; CASPASE 3; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRORETINOGRAPHY; ERYTHROPOIETIN, RECOMBINANT; IN SITU NICK-END LABELING; INTRAVITREAL INJECTIONS; LIGHT; MALE; MAP KINASE KINASE 1; MAP KINASE KINASE 2; RADIATION INJURIES, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RETINAL DEGENERATION; STAT5 TRANSCRIPTION FACTOR;

EID: 79960726362     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2011.582661     Document Type: Article

References (35)

1. Wu J, Seregard S, Algvere PV. Photochemical damage of the retina. Surv Ophthalmol 2006; 51: 461-481. (Pubitemid 44301311)
2. Algvere PV, Marshall J, Seregard S. Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmol Scand. 2006;84:4-15. (Pubitemid 43337467)
3. Wenzel A, Grimm C, Samardzija M, et al. Molecular mechanisms of light-induced photoreceptor apoptosis and neu-roprotection for retinal degeneration. Prog Retin Eye Res. 2005;24:275-306. (Pubitemid 40021788)
4. Organisciak DT, Darrow RM, Barsalou L, et al. Circadian-dependent retinal light damage in rats. Invest Ophthalmol Vis Sci. 2000;41:3694-3701.
5. Nir I, Liu C, Wen R. Light treatment enhances photoreceptor survival in dystrophic retinas of Royal College of Surgeons rats. Invest Ophthalmol Vis Sci. 1999;40:2383-2389.
6. Tomita H, Kotake Y, Anderson RE. Mechanism of protection from light-induced retinal degeneration by the synthetic anti-oxidant phenyl-N-tert-butylnitrone. Invest Ophthalmol Vis Sci. 2005;46:427-434. (Pubitemid 40270318)
7. Byrnes GA, Chang B, Loose I, et al. Prospective incidence of photic maculopathy after cataract surgery. Am J Ophthalmol. 1995;119:231-232.
8. Kohnen S. Light-induced damage of the retina through slit-lamp photography. Graefe's Arch Clin Exp Ophthalmol. 2000;238:956-959. (Pubitemid 32000756)
9. Kocsis I, Treszl A, Vasarhelyi B. Role of erythropoietin in brain homeostasis, neurodevelopment and neuroprotection. Orv Hetil. 2005;146:2527-2532. (Pubitemid 46141539)
10. Kretz A, Happold CJ, Marticke JK, et al. Erythropoietin promotes regeneration of adult CNS neurons via Jak2/ Stat3 and PI3K/AKT pathway activation. Mol Cell Neurosci. 2005;29:569-579. (Pubitemid 40984698)
11. Becerra P, Amaral J. Erythropoietin: An endogenous retinal survival factor. N Engl J Med. 2002;347:l968-l970.
12. Grimm C, Wenzel A, Groszer M, et al. HIF-1 induced eryth-ropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 2002;8:718-724. (Pubitemid 34778725)
13. Ranchon Cole I, Bonhomme B, Doly M. Pre-treatment of adult rats with high doses of erythropoietin induces cas-pase-9 but prevents light-induced retinal injury. Exp Eye Res. 2007;85:782-789. (Pubitemid 350176578)
14. Chung H, Lee H, Lamoke F, et al. Neuroprotective role of erythropoietin by antiapoptosis in the retina. J Neurosci Res. 2009;87:2365-2374.
15. Jaquet K, Krause K, Tawakol-Khodai M, et al. Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res. 2002;64:326-333.
16. Junk AK, Mammis A, Savitz SI, et al. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA. 2002;99:10659-10664FFFFFF0E
17. Fu QL, Wu W, Wang H, et al. Up-regulated endogenous erythropoietin /erythropoietin receptor system and exogenous erythropoietin rescue retinal ganglion cells after chronic ocular hypertension. Cell Mol Neurobiol. 2008;28:317-329. (Pubitemid 351253068)
18. Weishaupt JH, Rohde G, Polking E, et al. Effect of erythropoi-etin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci. 2004;45:1514-1522. (Pubitemid 38859333)
19. Zhang J, Wu Y, Jin Y, et al. Intravitreal injection of erythropoietin protects both retinal vascular and neu-ronal cells in early diabetes. Invest Ophthalmol Vis Sci. 2008;49:732-742.
20. Tsai JC, Wu L, Worgul B, et al. Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma. Curr Eye Res. 2005;30:1025-1031. (Pubitemid 43154696)
21. Rex TS, Allocca M, Domenici L, et al. Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration. Mol Ther. 2004;10:855-861. (Pubitemid 39419912)
22. Rex TS, Wong Y, Kodali K, et al. Neuroprotection of pho-toreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse. Exp Eye Res. 2009;89:735-740.
23. Xie Z, Wu X, Gong Y, et al. Intraperitoneal injection of Ginkgo biloba extract enhances antioxidation ability of retina and protects photoreceptors after light-induced retinal damage in rats. Curr Eye Res. 2007;32:471-479. (Pubitemid 46789423)
24. Gong YY, Song Y, Xie ZG, et al. Protective effect of Huangban Granule against light-induced retinal damage in rats. Zhong Xi Yi Jie He Xue Bao. 2008;6:1159-1163.
25. Li F, Cao W, Anderson RE. Alleviation of constant-light-induced photoreceptor degeneration by adaptation of adult albino rat to bright cyclic light. Invest Ophthalmol Vis Sci. 2003;44:4968-4975. (Pubitemid 37321345)
26. King CE, Rodger J, Bartlett C, et al. Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection. Exp Neurol. 2007;205:48-55. (Pubitemid 46617489)
27. Jehle T, Meschede W, Dersch R, et al. Erythropoietin protects retinal ganglion cells and visual function after ocular ischemia and optic nerve compression. Ophthalmologe. 2010;107:347-353.
28. Sakanaka M, Wen T-C, Matsuda S, et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA. 1998;95:4635-4640. (Pubitemid 28207965)
29. Zhang JF, Wu YL, Xu JY, et al. Pharmacokinetic and toxicity study of intravitreal erythropoietin in rabbits. Acta Pharmacol Sin. 2008;29:1383-1390.
30. Tsai JC. Safety of intravitreally administered recombinant erythropoietin (an AOS thesis). Trans Am Ophthalmol Soc. 2008;106:459-472.
31. Song BJ, Cai H, Tsai JC, et al. Intravitreal recombinant human erythropoietin: A safety study in rabbits. Curr Eye Res. 2008;33:750-760.
32. Lagrèze WA, Feltgen N, Bach M, et al. Feasibility of intrav-itreal erythropoietin injections in humans. Br J Ophthalmol. 2009;93:1667-1671.
33. Modarres M, Ghasemi Falavarjani K, Nazari H, et al. Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol.; 2010 Dec 3. [Epub ahead of print]
34. Grimm C, Wenzel A, Stanescu D, et al. Constitutive overex-pression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci. 2004;24:5651-5658. (Pubitemid 38857219)
35. Kilic U, Kilic E, Soliz J, et al. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. FASEB J. 2005;19:249-251. (Pubitemid 40189271)